Englander Institute for Precision Medicine

NK cells beat T cells at early breast cancer control.

TitleNK cells beat T cells at early breast cancer control.
Publication TypeJournal Article
Year of Publication2020
AuthorsBuqué A, Bloy N, Petroni G, Kroemer G, Galluzzi L
JournalOncoimmunology
Volume9
Issue1
Pagination1806010
Date Published2020 Aug 23
ISSN2162-4011
KeywordsAnimals, CD8-Positive T-Lymphocytes, Killer Cells, Natural, Mice, Neoplasms
Abstract

Cancer immunosurveillance generally relies on adaptive immune programs executed by CD8 T cells. Our findings demonstrate that CD8 T cells fail to control early oncogenesis in a mouse model of luminal B breast cancer and suggest that natural killer (NK) cells may instead play a predominant role in this setting.

DOI10.1080/2162402X.2020.1806010
Alternate JournalOncoimmunology
PubMed ID32923169
PubMed Central IDPMC7458610

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021